You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LGND Exercise Disclosure
Reardon Andrew · SEC Form 4 · Filed Aug 4, 2026
Exercise
Calculated transaction value
$0
Reardon Andrew CLO & Secretary
LGND
Transaction date
Aug 3, 2026
Public filing date
Aug 4, 2026
Filing lag
Filed 1 day later
LGND daily price context
Close on/before transaction
$292.04
Aug 3, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 5,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002001011-26-000111
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$1.71M
Buys / sales
0 / 10
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $58.12K |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $295.97K |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $145.77K |
| Ligand Pharmaceuticals Inc LGND Current | Exercise | Aug 3, 2026 | $0 |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $102.79K |
| Ligand Pharmaceuticals Inc LGND | Exercise | Aug 3, 2026 | $261.35K |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $29.83K |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $44.86K |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $289.09K |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $9.39K |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $119.76K |
| Ligand Pharmaceuticals Inc LGND | Sale | Aug 3, 2026 | $349.36K |